An increased glucose requirement by many solid tumors produces an:increased
metabolic demand on the Liver, resulting in an increased energy expenditur
e. In:addition, several cytokines and tumor catabolic products have been su
ggested as being responsible for the depletion of adipose tissue and skelet
al-muscle mass in cachexia. A sulphated glycoprotein of molecular mass 24 k
Da, produced by-cachexia-inducing tumors and present in the urine of cancer
patients actively losing weight, has been shown to be capable of inducing
direct muscle catabolism in vitro and a state of cachexia in vivo, with spe
cific lass of the non-fat carcass mass. In vitro studies have shown the bio
activity of this proteolysis-inducing factor to be attenuated by the polyun
saturated fatty acid, eicosapentaenoic acid. Preliminary clinical studies,
have shown that eicosapentaenoic acid stabilizes body weight and protein an
d fat reserves in patients with pancreatic carcinoma. Further trials are re
quired to confirm the efficacy of eicosapentaenoic acid and to determine th
e anticachectic activity in other types of cancer. Nutrition 2000;16:1013-1
014. (C) Elsevier Science Inc. 2000.